Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 5.48M | $11.0M | 9.08% | -- | 2026-06-30 |
| AQR Capital Management LLC | 3.75M | $7.0M | 6.22% | +921.7K | 2026-06-30 |
| Kingdon Capital Management, L.L.C. | 2.65M | $5.0M | 4.40% | +500.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.36M | $5.0M | 3.92% | -1.9K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 1.94M | $4.0M | 3.22% | +536.3K | 2026-06-30 |
| Marshall Wace, LLP | 1.51M | $3.0M | 2.50% | +1.38M | 2026-06-30 |
| 683 Capital Management, LLC | 1.45M | $3.0M | 2.40% | -50.0K | 2026-06-30 |
| Jane Street Group, LLC | 1.40M | $2.0M | 2.31% | +255.4K | 2026-06-30 |
| Ardsley Advisory Partners LP | 1.27M | $2.0M | 2.11% | +25.0K | 2026-06-30 |
| BlackRock, Inc. | 1.26M | $2.0M | 2.08% | -2.51M | 2026-06-30 |
